Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12551562 | Methods and compositions for irreversible enzyme inhibition | 🖼🧊📄§ | 2026-02-17 | 2040-04-10 | 0 | 31 |
| 12551506 | Differentiation of olfactory mucosa derived mesenchymal stem cells to schwann cells for peripheral nerve repair | 🖼🧊📄§ | 2026-02-17 | 2042-04-25 | 0 | 31 |
| 12552840 | Identification of inhibitor peptides to bind with n-terminal spike (s) and nonstructural protein (NSP) sequences of SARS-COV2 b.1.617.2 Delta or Omicron variants alone and combination with drug(s) for targeted antiviral therapy | 🖼🧊📄§ | 2026-02-17 | 2042-05-04 | 0 | 31 |
| 12552846 | Modified BCL9 mimetic peptides | 🖼🧊📄§ | 2026-02-17 | 2040-07-06 | 0 | 31 |
| 12551528 | Compounds and methods for treating or reducing pruritus | 🖼🧊📄§ | 2026-02-17 | 2041-01-25 | 0 | 31 |
| 12551547 | Highly networked immunogen composition | 🖼🧊📄§ | 2026-02-17 | 2040-03-12 | 0 | 31 |
| 12552834 | Selective MENA binding peptides | 🖼🧊📄§ | 2026-02-17 | 2042-01-25 | 0 | 31 |
| 12551527 | Drug delivery systems for treatment of infections | 🖼🧊📄§ | 2026-02-17 | 2038-12-28 | 0 | 31 |
| 12551511 | Methods to differentiate stem cells into hormone-producing cells | 🖼🧊📄§ | 2026-02-17 | 2042-09-09 | 0 | 31 |
| 12552849 | Method of reducing bispecific t cell engager or chimeric antigen receptor t cell mediated cytokine release syndrome using interleukins-4, -10, or a fusion protein thereof | 🖼🧊📄§ | 2026-02-17 | 2044-09-09 | 0 | 31 |
| 12551512 | Therapeutic efficacy by pulmonary delivery of live attenuated mycobacteria | 🖼🧊📄§ | 2026-02-17 | 2040-09-28 | 0 | 31 |
| 12551504 | Mitochondrial augmentation therapy of pancreatic diseases | 🖼🧊📄§ | 2026-02-17 | 2039-07-22 | 0 | 31 |
| 12552869 | CSF-1R antibodies for the treatment of chronic graft versus host disease | 🖼🧊📄§ | 2026-02-17 | 2040-12-09 | 0 | 31 |
| 12551498 | Treatment of P53-deficient cancers | 🖼🧊📄§ | 2026-02-17 | 2040-07-27 | 0 | 31 |
| 12551733 | Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-02-05 | 0 | 31 |
| 12552765 | Small molecule modulators of pantothenate kinases | 🖼🧊📄§ | 2026-02-17 | 2040-12-14 | 0 | 31 |
| 12551505 | Composition for bone regeneration comprising METTL7A overexpressing stem cells, method for preparing same, and cell therapy product comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-06-18 | 0 | 31 |
| 12552865 | High affinity nanobodies targeting B7-H3 (CD276) for treating multiple solid tumors | 🖼🧊📄§ | 2026-02-17 | 2040-10-21 | 0 | 31 |
| 12552855 | CD33 targeted immunotherapies | 🖼🧊📄§ | 2026-02-17 | 2040-05-07 | 0 | 31 |
| 12551529 | Liquid formulation of a VEGF antagonist | 🖼🧊📄§ | 2026-02-17 | 2043-02-23 | 0 | 31 |
| 12551517 | Probiotics for cognitive and mental health | 🖼🧊📄§ | 2026-02-17 | 2042-09-30 | 0 | 31 |
| 12552760 | Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof | 🖼🧊📄§ | 2026-02-17 | 2043-04-21 | 0 | 31 |
| 12551436 | Dosing regimens for treatment of proliferative disorders | 🖼🧊📄§ | 2026-02-17 | 2043-10-04 | 0 | 31 |
| 12551468 | Pharmaceutical composition for oral administration, for treatment of liver cancer | 🖼🧊📄§ | 2026-02-17 | 2040-11-25 | 0 | 31 |
| 12551478 | Quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity | 🖼🧊📄§ | 2026-02-17 | 2039-09-25 | 0 | 31 |
| 12551465 | Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition | 🖼🧊📄§ | 2026-02-17 | 2041-04-22 | 0 | 31 |
| 12551518 | Probiotic system and use thereof | 🖼🧊📄§ | 2026-02-17 | 2040-12-11 | 0 | 31 |
| 12551525 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | 🖼🧊📄§ | 2026-02-17 | 2045-03-20 | 0 | 31 |
| 12551474 | Use of pridopidine for the treatment of fragile X syndrome | 🖼🧊📄§ | 2026-02-17 | 2042-01-31 | 0 | 31 |
| 12551493 | Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same | 🖼🧊📄§ | 2026-02-17 | 2040-10-21 | 0 | 31 |
| 12551513 | Bacillus coagulans having blood glucose reduction efficacy, and application thereof | 🖼🧊📄§ | 2026-02-17 | 2041-06-21 | 0 | 31 |
| 12552787 | Quinazoline compound | 🖼🧊📄§ | 2026-02-17 | 2041-07-23 | 0 | 31 |
| 12551467 | Compositions and methods of modulating S-nitrosylation | 🖼🧊📄§ | 2026-02-17 | 2042-08-30 | 0 | 31 |
| 12551475 | Methods and compositions for treating RNA viral infections | 🖼🧊📄§ | 2026-02-17 | 2041-06-01 | 0 | 31 |
| 12552782 | Analogs of nitrofuran antibiotics to combat resistance | 🖼🧊📄§ | 2026-02-17 | 2043-01-17 | 0 | 31 |
| 12551542 | Polymeric nanoparticles that target liver sinusoidal endothelial cells to induce antigen-specific immune tolerance | 🖼🧊📄§ | 2026-02-17 | 2040-11-11 | 0 | 31 |
| 12551543 | Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof | 🖼🧊📄§ | 2026-02-17 | 2042-03-10 | 0 | 31 |
| 12551734 | Betacoronavirus mRNA vaccines | 🖼🧊📄§ | 2026-02-17 | 2044-12-23 | 0 | 31 |
| 12551523 | HIF-1 activator | 🖼🧊📄§ | 2026-02-17 | 2042-10-04 | 0 | 31 |
| 12553903 | Ivaltinostat combination therapy for treating pancreatic cancer | 🖼🧊📄§ | 2026-02-17 | 2044-05-07 | 0 | 31 |
| 12551545 | African swine fever virus chimeric protein, vaccine composition, preparation method and use thereof | 🖼🧊📄§ | 2026-02-17 | 2041-03-09 | 0 | 31 |
| 12551548 | HIV vaccine compositions, methods, and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-06-10 | 0 | 31 |
| 12552851 | T cell receptors with VGLL1 specificity and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-05-21 | 0 | 31 |
| 12552873 | Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2040-06-02 | 0 | 31 |
| 12553041 | Formulations and doses of pegylated uricase | 🖼🧊📄§ | 2026-02-17 | 2040-06-04 | 0 | 31 |
| 12551477 | Oral antagonist compositions for nicotine burning relief | 🖼🧊📄§ | 2026-02-17 | 2040-09-22 | 0 | 31 |
| 12551546 | Materials and methods relating to immunogenic epitopes from human papilloma virus | 🖼🧊📄§ | 2026-02-17 | 2044-03-06 | 0 | 31 |
| 12551568 | Anti-claudin 6 antibody and antibody-drug conjugate | 🖼🧊📄§ | 2026-02-17 | 2042-06-17 | 0 | 31 |
| 12552850 | GLP-1/GIP dual agonist, long-acting conjugate thereof, and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-10-18 | 0 | 31 |
| 12551495 | Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infection | 🖼🧊📄§ | 2026-02-17 | 2041-03-24 | 0 | 31 |